12 mg semaglutide Once-weekly 2.4 led to significant decreases in body weight and fat mass over months while preserving lean mass and improved muscle function in adults with obesity. Weight and fat Semaglutide: 120mg | Supopeptide

Vomiting Vomiting is less common than nausea but still affects roughly 10% to 15% of people, particularly at higher doses

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

Diabetes Obes Metab 25(1):1835 Webster CM et al (2023) Potential contributors to variation in weight-loss response to liraglutide

Learn About 3mg, 7mg, and 14mg Tablets: Rybelsus is the brand-prescribed medication used to treat type 2 diabetes